Korsana Biosciences
PublicKorsana Biosciences is now publicly traded
The data on this page reflects Korsana Biosciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
PIPE
Apr 1, 2026
Total Funding Raised
$730M
Company Overview
Korsana Biosciences is a biotechnology company developing brain-penetrant therapeutics for neurodegenerative diseases using its proprietary blood-brain barrier shuttle platform.
AI Layer
Non-AI
Keywords
Korsana Biosciences Comparables
Compare Korsana Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoNewron, Inc. | 81% | |
| AbbVie | 78% | |
| SciNeuro Pharmaceuticals | 76% |
Korsana Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Apr 1, 2026 | ||||
| Seed | Feb 18, 2026 | ||||
| Series A | Sep 1, 2025 | ||||
| Seed | Dec 1, 2024 |
Key People
Founding team and executive leadership
Korsana Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | PIPE, Seed, Series A |
| RA Capital Management | PIPE |
| TCG Crossover | PIPE, Seed, Series A |
| Forbion | PIPE |
| Fairmount Funds Management | Seed, PIPE |
| Commodore Capital | PIPE |
| Kalehua Capital Management | PIPE |
Recent news
Latest coverage and updates
- receives_financingSep 8, 2026
Korsana Biosciences, Inc. received financing of $380M in private financing on Sep 8th '26.
Korsana Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access